Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...

At ARVO 2025, in Salt Lake City, Utah, Ferhina Ali, MD, MPH, talked about her presentation on the early real-world use of aflibercept 8 mg in treatment-naive patients with neovascular age-related macu ...

Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...

The VR experiences feature videos showing real people — actors portraying relatives and caregivers — interacting with users, ...

At ARVO 2025, in Salt Lake City, Utah, Diana Do, MD, gave an update on the LIGHTSITE III study of photobiomodulation for dry age-related macular degeneration.

Researcher works with universities of California-Davis, Illinois, Wisconsin and others to engineer and test a novel microsphere-hydrogel delivery for medicine, requiring fewer injections, to treat a c ...

Researchers found the therapy downregulated VEGF expression and improved retinal thickness in neovascular age-related macular degeneration patients.

- Cash Position: Cash and cash equivalents were $101.6 million as of March 31, 2025, compared to $34.6 million as of December 31, 2024, bolstered by $76.4 million in gross proceeds from the first ...

Researchers presented an exploratory analysis comparing OCT biomarkers in a Phase 1b study of ONL1204 in patients with ...

The extension trial findings for LumiThera’s Valeda dry AMD treatment suggest longer treatment and earlier intervention ...

Alvin Luk, CEO of HuidaGene, is using his experience in big pharma to lead the small Shanghai and New Jersey-based biotech on ...